Cellebrite Other Assets from 2010 to 2024

CLBT Stock  USD 19.72  0.46  2.28%   
Cellebrite Other Assets yearly trend continues to be comparatively stable with very little volatility. Other Assets will likely drop to about 10.3 M in 2024. From the period from 2010 to 2024, Cellebrite Other Assets quarterly data regression had r-value of  0.79 and coefficient of variation of  71.10. View All Fundamentals
 
Other Assets  
First Reported
2010-12-31
Previous Quarter
16.4 M
Current Value
10.3 M
Quarterly Volatility
4.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cellebrite financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellebrite's main balance sheet or income statement drivers, such as Tax Provision of 4 M, Interest Income of 8.4 M or Depreciation And Amortization of 8 M, as well as many indicators such as Price To Sales Ratio of 6.58, Dividend Yield of 0.0818 or PTB Ratio of 50.54. Cellebrite financial statements analysis is a perfect complement when working with Cellebrite Valuation or Volatility modules.
  
Check out the analysis of Cellebrite Correlation against competitors.

Latest Cellebrite's Other Assets Growth Pattern

Below is the plot of the Other Assets of Cellebrite DI over the last few years. It is Cellebrite's Other Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellebrite's overall financial position and show how it may be relating to other accounts over time.
Other Assets10 Years Trend
Slightly volatile
   Other Assets   
       Timeline  

Cellebrite Other Assets Regression Statistics

Arithmetic Mean6,396,637
Geometric Mean5,274,146
Coefficient Of Variation71.10
Mean Deviation3,818,182
Median3,533,000
Standard Deviation4,547,950
Sample Variance20.7T
Range12.8M
R-Value0.79
Mean Square Error8.5T
R-Squared0.62
Significance0.0005
Slope800,456
Total Sum of Squares289.6T

Cellebrite Other Assets History

202410.3 M
202316.4 M
202214.2 M
202111.8 M
20207.9 M

About Cellebrite Financial Statements

Cellebrite shareholders use historical fundamental indicators, such as Other Assets, to determine how well the company is positioned to perform in the future. Although Cellebrite investors may analyze each financial statement separately, they are all interrelated. The changes in Cellebrite's assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellebrite's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Assets16.4 M10.3 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellebrite Stock Analysis

When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.